These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 48105)
21. [Current indications for levamisole]. Matkovics A Orv Hetil; 2004 Oct; 145(44):2259-60. PubMed ID: 15626175 [No Abstract] [Full Text] [Related]
22. In vitro stimulation of tumor-associated immunity in prostatic cancer by levamisole. Zamora S; Bhatti RA; Ablin RJ; Rao R; Baumgartner G; Guinan PD Cell Mol Biol Incl Cyto Enzymol; 1979; 25(1):57-9. PubMed ID: 574794 [No Abstract] [Full Text] [Related]
23. [Therapy of myocarditis with levamisole]. Niedworok J; Goch JH; Kulig H; Tkaczewski W; Kuklewicz C Z Gesamte Inn Med; 1986 Aug; 41(16):456-8. PubMed ID: 3776260 [TBL] [Abstract][Full Text] [Related]
25. Effect of levamisole on malignant experimental neurinoma grown subcutaneously in a young rat: brief communication. Aleksic S; Drnovski F; Bloom A; Rappaport H; Ransohoff J J Natl Cancer Inst; 1977 Nov; 59(5):1567-7. PubMed ID: 909113 [TBL] [Abstract][Full Text] [Related]
26. [The immunomodulating effect of levamisole in animal experiments]. Sikorska H Reumatologia; 1979; 17(3):339-47. PubMed ID: 390660 [No Abstract] [Full Text] [Related]
27. Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer. Stevenson HC; Green I; Hamilton JM; Calabro BA; Parkinson DR J Clin Oncol; 1991 Nov; 9(11):2052-66. PubMed ID: 1941064 [TBL] [Abstract][Full Text] [Related]
28. Levamisole in the treatment of Crohn's disease. Segal AW; Levi AJ; Loewi G Lancet; 1977 Aug; 2(8034):382-5. PubMed ID: 70591 [TBL] [Abstract][Full Text] [Related]
29. Some aspects of host response to levamisole after chemotherapy in a murine leukemia. Perk K; Chirigos MA; Fuhrman F; Pettigrew H J Natl Cancer Inst; 1975 Jan; 54(1):253-6. PubMed ID: 1113305 [TBL] [Abstract][Full Text] [Related]
30. Levamisole, rheumatoid arthritis, and cold lymphocytotoxic antibodies. Browning JD; Dick HM; El-Ghobarey A; Dick WC Lancet; 1977 Oct; 2(8042):820. PubMed ID: 71625 [No Abstract] [Full Text] [Related]
31. [Clinico-immunological evaluation of the levamisole treatment of chronic glomerulonephritis patients]. Pyrig LA; Kolesnik NA Vrach Delo; 1983 Mar; (3):95-8. PubMed ID: 6858119 [No Abstract] [Full Text] [Related]
32. [Correlation between the immune reaction and clinical course in a bullous pemphigoid case treated with levamisole]. Carli-Basset C; Renoux M; Pauley AM; Lorette G; Renoux G LARC Med; 1982 May; 2(5):440-1. PubMed ID: 6762474 [No Abstract] [Full Text] [Related]
33. Levamisole in cancer treatment: modifications in time of cellular immunity. (Preliminary report). Luporini G; Fraschini P; Labianca R; Negri R Boll Ist Sieroter Milan; 1979 Nov; 58(5):435-9. PubMed ID: 576007 [TBL] [Abstract][Full Text] [Related]
35. High frequency of agranulocytosis in breast-cancer patients treated with levamisole. Teerenhovi L; Heinonen E; Gröhn P; Klefström P; Mehtonen M; Tiilikainen A Lancet; 1978 Jul; 2(8081):151-2. PubMed ID: 78345 [No Abstract] [Full Text] [Related]
36. [Chemo-immunotherapy of acute myeloid leukemia with levamisole and 9 cytostatics]. Brincker H; Thorling K; Jensen B Ugeskr Laeger; 1977 Feb; 139(9):521-4. PubMed ID: 320739 [No Abstract] [Full Text] [Related]
37. Letter: Levamisole and the immune response. N Engl J Med; 1973 Nov; 289(21):1148-9. PubMed ID: 4585358 [No Abstract] [Full Text] [Related]
38. Levamisole in the treatment of cancer: anything new? (Review). De Brabander M; De Crée J; Vandebroek J; Verhaegen H; Janssen PA Anticancer Res; 1992; 12(1):177-87. PubMed ID: 1567166 [TBL] [Abstract][Full Text] [Related]